A Study of VRG50635 in Healthy Volunteers

• Status: COMPLETED
• Trial end date: 2024-04-08

Summary

The primary objectives of this study are to investigate the safety and tolerability of VRG50635 and to determine how VRG50635 is absorbed by the body.

• Phase: PHASE1

Details

• Lead Sponsor: Verge Genomics